POLE2
Basic information
Region (hg38): 14:49643555-49688422
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (358 variants)
- not_specified (53 variants)
- POLE2-related_disorder (10 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the POLE2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000002692.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 9 | 47 | 6 | 62 | ||
| missense | 177 | 6 | 5 | 188 | ||
| nonsense | 7 | 7 | ||||
| start loss | 0 | |||||
| frameshift | 12 | 12 | ||||
| splice donor/acceptor (+/-2bp) | 7 | 7 | ||||
| Total | 0 | 0 | 212 | 53 | 11 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| POLE2 | protein_coding | protein_coding | ENST00000216367 | 19 | 44868 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 2.85e-7 | 0.996 | 125678 | 0 | 66 | 125744 | 0.000262 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.791 | 232 | 268 | 0.864 | 0.0000136 | 3432 |
| Missense in Polyphen | 56 | 76.44 | 0.7326 | 1017 | ||
| Synonymous | 0.0667 | 89 | 89.8 | 0.991 | 0.00000446 | 957 |
| Loss of Function | 2.60 | 16 | 31.8 | 0.503 | 0.00000163 | 408 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000412 | 0.000396 |
| Ashkenazi Jewish | 0.0000993 | 0.0000992 |
| East Asian | 0.000170 | 0.000163 |
| Finnish | 0.000185 | 0.000185 |
| European (Non-Finnish) | 0.000421 | 0.000413 |
| Middle Eastern | 0.000170 | 0.000163 |
| South Asian | 0.0000691 | 0.0000653 |
| Other | 0.000165 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Participates in DNA repair and in chromosomal DNA replication.;
- Pathway
- Nucleotide excision repair - Homo sapiens (human);Pyrimidine metabolism - Homo sapiens (human);Base excision repair - Homo sapiens (human);HTLV-I infection - Homo sapiens (human);DNA replication - Homo sapiens (human);Purine metabolism - Homo sapiens (human);Retinoblastoma (RB) in Cancer;Pyrimidine metabolism;G1 to S cell cycle control;DNA Replication;HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);DNA Repair;DNA Double-Strand Break Repair;Homology Directed Repair;Purine metabolism;Activation of the pre-replicative complex;Mitotic G1-G1/S phases;DNA replication initiation;DNA Replication;Pyrimidine metabolism;Synthesis of DNA;S Phase;PCNA-Dependent Long Patch Base Excision Repair;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;Resolution of Abasic Sites (AP sites);Base Excision Repair;Telomere C-strand synthesis initiation;Telomere C-strand (Lagging Strand) Synthesis;Extension of Telomeres;Telomere Maintenance;Chromosome Maintenance;G1/S Transition;Recognition of DNA damage by PCNA-containing replication complex;DNA Replication Pre-Initiation;M/G1 Transition;Termination of translesion DNA synthesis;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;DNA Damage Bypass;Cell Cycle;Dual Incision in GG-NER;Gap-filling DNA repair synthesis and ligation in GG-NER;Global Genome Nucleotide Excision Repair (GG-NER);Cell Cycle, Mitotic;Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Nucleotide Excision Repair;HDR through Homologous Recombination (HRR)
(Consensus)
Recessive Scores
- pRec
- 0.0896
Intolerance Scores
- loftool
- 0.830
- rvis_EVS
- 0.15
- rvis_percentile_EVS
- 64.61
Haploinsufficiency Scores
- pHI
- 0.962
- hipred
- Y
- hipred_score
- 0.590
- ghis
- 0.620
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.703
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pole2
- Phenotype
Zebrafish Information Network
- Gene name
- pole2
- Affected structure
- trunk
- Phenotype tag
- abnormal
- Phenotype quality
- necrotic
Gene ontology
- Biological process
- G1/S transition of mitotic cell cycle;DNA replication;DNA-dependent DNA replication;DNA repair;error-prone translesion synthesis
- Cellular component
- nucleoplasm;epsilon DNA polymerase complex;nuclear body;intracellular membrane-bounded organelle
- Molecular function
- DNA binding;DNA-directed DNA polymerase activity;protein binding